durvalumab,paclitaxel,carboplatin,cisplatin,gemcitabine,pemetrexed
astrazeneca
['aegean']
 aegean f #aacr23 pcr: 17.2% vs 4.3% ( 13%) high consistency across predefined subgroups, including pd-l1 expression. never smoking pts population should be better characterized with ngs molecular profiling 
MD PhD, lung oncologist & researcher @IEOufficiale; @myESMO Communication Committee Chair; #LungCancer Molecular target-believer #LCSM